Hyperglycaemic Hyperosmolar Syndrome

Severe hyperglycaemia without significant ketosis; the characteristic metabolic emergency of T2DM

Aetiology

  • People present in middle or later life, often with previously undiagnosed diabetes
  • Common precipitating factors include consumption of glucose-rich fluids, concurrent medication such as thiazide diuretics or steroids, and intercurrent illness

Pathophysiology

  • Pathophysiology is similar to DKA, but HHS, there are still small amounts of insulin being secreted by the pancreas
  • This is sufficient to prevent DKA by suppressing lipolysis and, in turn, ketogenesis, but level is not high enough to lower blood glucose to a safe level
  • HHS is characterized by symptoms of marked dehydration (and loss of electrolytes) due to the predominating hyperglycaemia and osmotic diuresis (hyperosmolar urine)

Clinical presentation

  • Dehydration due to polyuria
  • Polydipsia
  • Nausea and vomiting
  • Stupor/coma
    • Impaired consiousness is directly related to degree of osmolarity

Investigations

HHS is characterised by:
  • Profound hyperglycaemia (blood glucose >600 mg/dL)
  • Hyperosmolality (serum osmolarity >320mmol/kg)
    • Can be measured directly or calculated as (2 x Na+) + glucose + urea
  • Volume depletion in the absence of ketoacidosis (pH >7.3 and bicarbonate >18mmol/L)

Other features

  • Significant renal impairment
  • Sodium often high normal or raised

Management

  • Assess severity of dehydration and use 0.9% saline for fluid replacement WITHOUT insulin - fluids alone will reduce osmolarity
    • Be aware of increased risk of fluid overload
  • Sodium - avoid rapid fluctuations, if dropping too quickly consider 0.45% saline
  • Monitor and chart BG, osmolarity and sodium
  • Start low dose IV insulin only if significant ketones (>1) or BG falling at a slow rate
  • Comorbidities more likely
    • Screen for vascular event e.g. silent MI
    • LMWH for all patients (unless contraindicated)
    • High risk of feet complications